It has been traditionally recommended that candidates for vascular surgery receive noninvasive stress perfusion testing risk stratification to help decide which patients may benefit from coronary artery revascularization. Recent clinical trials have contested the efficacy of revascularization in this population as well as the information yield of noninvasive testing. This article reviews a number of these studies that are likely to change our beliefs regarding testing and subsequent interventions as well as evolving role of medical therapy in patients undergoing vascular surgery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/1089253211416517 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!